Financing round-up: Tridek-One, SparingVision, WhiteLab Genomics, Nutromics, AnaCardio

Sweden: AnaCardio, a clinical stage biopharmaceutical company developing novel drugs to treat heart failure, has raised Skr150m (US$14.4m)  in a Series A financing round, co-led by Flerie Invest and Industrifonden. 3B Future Health Fund (3BFHF) joined Flerie and Industrifonden to complete the round together with the founding investor Karolinska Development and current investors Fredrik and…

You must be a HMI Subscriber to view this content.

Subscribe Now »